Buy GHK-Cu 50 mg by Kalpa Pharmaceuticals at Best Anabolic Steroids. The pack is a single freeze-dried vial holding fifty milligrams of a copper peptide: three amino acids joined to one copper ion in a fixed one-to-one complex. The sequence occurs naturally in human plasma and appears in saliva and urine, which is what makes it interesting to researchers rather than exotic.
Anyone mixing it will notice the colour immediately. Once bacteriostatic water is added, the solution turns pale blue-green, and that tint is the copper in the complex. It is the simplest way to tell a genuine preparation from a vial of water, and it should stay clear rather than cloudy.
Product Overview
The peptide is a small molecule, which changes how its data reads. Most published work has been done in cell culture or with topical application, where the compound was studied for its effect on collagen synthesis, glycosaminoglycans and wound contraction in fibroblast models. That is a substantial body of laboratory evidence and a very thin body of human evidence at the same time.
Two gaps define how the vial should be treated. First, no human half-life has been established for GHK-Cu, and the sources state that directly rather than offering a range. Second, no human dosing schedule for injection exists, so every number circulating in the market is an extrapolation from models or a vendor convention. Anyone comparing this peptide with a licensed medicine is comparing a research tool with a drug, and the two do not share a standard. The Kali catalogue keeps the same handling rules across its peptide line, from Bacteriostatic Water to the repair vial BPC 157 and the metabolic packs Mounjarixyl and Kalpatropin 100 IU.
Dosage Protocol
There is no human dose, so this table is a set of mixing volumes and research amounts rather than a protocol. Every figure below is arithmetic or a model-based convention.
| Beginner | Dissolve a 50 mg vial in 5 ml of water for 10 mg per ml, so 0.1 ml is 1 mg and 10 units on a U-100 syringe is 1 mg |
| Intermediate | Two millilitres of water gives 25 mg per ml, which suits small volumes but doubles the cost of a measuring error |
| Advanced | Research amounts quoted in model work sit near 1-2 mg per day systemically; no reviewed human dose supports that figure |
| Female | Nothing separate appears in the sources reviewed; the material is a research item rather than a dosed medicine |
| Administration | Subcutaneous or intramuscular for the mixed vial; the same compound is studied topically, which is where most data sits |
Three habits protect the material. Mix gently and never shake, because a foaming peptide degrades. Keep the sealed vial cold and the mixed vial in the refrigerator, using it inside the vendor window. And record the concentration on the label the same minute it is mixed, since 10 units means 1 mg only at the 10 mg per ml ratio.
Suggested Protocols
This peptide is rarely discussed on its own. It is placed next to other repair-focused compounds, and the protocols below describe that context rather than a formal stack.
Where an oil-based course is running at the same time, the hygiene rules do not change: a mixed peptide is handled exactly like Masteroxyl 100, with a fresh needle and a swabbed stopper every time.
What to Expect
- No human timeline exists. The described effects come from wound models and cell studies, so any expectation about speed rests on vendor wording rather than on trial data.
- What the literature describes. Stimulated collagen and glycosaminoglycan production in fibroblasts, faster wound contraction in animal models, and an anti-inflammatory signal in the same experiments.
- A solution that looks like copper. A blue-green tint after mixing is expected. Cloudiness, particles or a colour shift after storage are not, and that vial should be discarded.
- Most data is topical, not injected. Applying the compound to skin is where the study base is thickest; injecting it is a community practice without a human safety record.
- Vendor arithmetic, not a dose. Every milligram figure in circulation is a starting convention, because no human pharmacokinetic profile has been fixed for this peptide.
- An unclear sporting status. No entry for GHK-Cu was found in the prohibited list searched for this fact sheet, which is not the same as an assurance that it is permitted.
Side Effects and Management
The copper content also means the material is not a cosmetic additive with no systemic reach. Anything injected enters circulation, and a compound without an established human safety record belongs in short, carefully observed blocks rather than in a permanent routine.
Post-Cycle Therapy and Follow-Up
Nothing about this peptide requires a restart protocol. GHK-Cu has no effect on testosterone production, so there is no suppression and nothing for a SERM to do at the end of a block. The end of a course is simply a pause.
Where an androgen such as Nandroxyl 250 runs alongside, its own recovery plan governs the end of the course and the peptide simply stops. Anyone injecting a research material for weeks should also keep the injection log they would keep for anything else: date, volume, site and any reaction.
